APA (7th ed.) Citation

Harutyunova, S., Benjamin, N., Eichstaedt, C., Marra, A. M., Xanthouli, P., Nagel, C., . . . Egenlauf, B. (2023). Long-term safety, outcome, and clinical effects of subcutaneous and intravenous treprostinil treatment in patients with severe chronic pulmonary arterial hypertension. Karger. https://doi.org/10.11588/heidok.00035530

Chicago Style (17th ed.) Citation

Harutyunova, Satenik, Nicola Benjamin, Christina Eichstaedt, Alberto M. Marra, Panagiota Xanthouli, Christian Nagel, Ekkehard Grünig, and Benjamin Egenlauf. Long-term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension. Basel: Karger, 2023. https://doi.org/10.11588/heidok.00035530.

MLA (9th ed.) Citation

Harutyunova, Satenik, et al. Long-term Safety, Outcome, and Clinical Effects of Subcutaneous and Intravenous Treprostinil Treatment in Patients with Severe Chronic Pulmonary Arterial Hypertension. Karger, 2023. https://doi.org/10.11588/heidok.00035530.